Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder

Cellular and Molecular Gastroenterology and Hepatology

Volumn 3, Issue 2, 2017, Pages 218-230

  Luna, Ruth Ann ^a,b   Oezguen, Numan ^a,b   Balderas, Miriam ^a,b   Venkatachalam, Alamelu ^a,b   Runge, Jessica K ^a,b   Versalovic, James ^a,b   Veenstra VanderWeele, Jeremy ^c   Anderson, George M ^d,e   Savidge, Tor ^a,b   Williams, Kent C ^f  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Columbia University ^*  (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Gastrointestinal Disorders; Microbiome; Microbiome Gut Brain Axis; Mucosa; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CYTOKINE; DNA 16S; SEROTONIN; TRYPTOPHAN;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; AUTISM; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLOSTRIDIALES; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; MICROBIOME; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RECTUM BIOPSY; SCHOOL CHILD; SOCIAL ADAPTATION; SUPERNATANT;

EID: 85011589286     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2016.11.008     Document Type: Article

References (64)

1. 1 Buie, T., Campbell, D.B., Fuchs, G.J. 3rd, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125:Suppl 1 (2010), S1–S18.
2. 2 McElhanon, B.O., McCracken, C., Karpen, S., et al. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 133 (2014), 872–883.
3. 3 Gorrindo, P., Williams, K.C., Lee, E.B., et al. Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res 5 (2012), 101–108.
4. 4 Horvath, K., Papadimitriou, J.C., Rabsztyn, A., et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 135 (1999), 559–563.
5. 5 Fulceri, F., Morelli, M., Santocchi, E., et al. Gastrointestinal symptoms and behavioral problems in preschoolers with autism spectrum disorder. Dig Liver Dis 48 (2016), 248–254.
6. 6 Furuta, G.T., Williams, K., Kooros, K., et al. Management of constipation in children and adolescents with autism spectrum disorders. Pediatrics 130:Suppl 2 (2012), S98–S105.
7. 7 Hyman, P.E., Milla, P.J., Benninga, M.A., et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 130 (2006), 1519–1526.
8. 8 Mayer, E.A., Tillisch, K., The brain-gut axis in abdominal pain syndromes. Annu Rev Med 62 (2011), 381–396.
9. 9 Mayer, E.A., Savidge, T., Shulman, R.J., Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146 (2014), 1500–1512.
10. 10 Levy, R.L., Olden, K.W., Naliboff, B.D., et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130 (2006), 1447–1458.
11. 11 Daly, E., Ecker, C., Hallahan, B., et al. Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion. Brain 137 (2014), 2600–2610.
12. 12 Croonenberghs, J., Wauters, A., Devreese, K., et al. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32 (2002), 1457–1463.
13. 13 Croonenberghs, J., Bosmans, E., Deboutte, D., et al. Activation of the inflammatory response system in autism. Neuropsychobiology 45 (2002), 1–6.
14. 14 Jyonouchi, H., Sun, S., Le, H., Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120 (2001), 170–179.
15. 15 Jyonouchi, H., Geng, L., Streck, D.L., et al. Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. J Neuroinflammation, 9, 2012, 4.
16. 16 Li, X., Chauhan, A., Sheikh, A.M., et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 207 (2009), 111–116.
17. 17 Chez, M.G., Dowling, T., Patel, P.B., et al. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36 (2007), 361–365.
18. 18 Croen, L.A., Grether, J.K., Yoshida, C.K., et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 68 (2011), 1104–1112.
19. 19 Kane, M.J., Angoa-Perez, M., Briggs, D.I., et al. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One, 7, 2012, e48975.
20. 20 Anderson, G., Maes, M., Redox regulation and the autistic spectrum: role of tryptophan catabolites, immuno-inflammation, autoimmunity and the amygdala. Curr Neuropharmacol 12 (2014), 148–167.
21. 21 O'Mahony, S.M., Clarke, G., Borre, Y.E., et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277 (2015), 32–48.
22. 22 Finegold, S.M., Dowd, S.E., Gontcharova, V., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16 (2010), 444–453.
23. 23 Williams, B.L., Hornig, M., Buie, T., et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One, 6, 2011, e24585.
24. 24 Gondalia, S.V., Palombo, E.A., Knowles, S.R., et al. Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 5 (2012), 419–427.
25. 25 Kang, D.W., Park, J.G., Ilhan, Z.E., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, 2013, e68322.
26. 26 De Angelis, M., Piccolo, M., Vannini, L., et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One, 8, 2013, e76993.
27. 27 Wang, L., Christophersen, C.T., Sorich, M.J., et al. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism, 4, 2013, 42.
28. 28 Wang, W., Chen, L., Zhou, R., et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52 (2014), 398–406.
29. 29 Li, G., Yang, M., Zhou, K., et al. Diversity of duodenal and rectal microbiota in biopsy tissues and luminal contents in healthy volunteers. J Microbiol Biotechnol 25 (2015), 1136–1145.
30. 30 Reigstad, C.S., Salmonson, C.E., Rainey, J.F. 3rd, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29 (2015), 1395–13403.
31. 31 Yano, J.M., Yu, K., Donaldson, G.P., et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
32. 32 Atarashi, K., Tanoue, T., Ando, M., et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163 (2015), 367–380.
33. 33 Ohnmacht, C., Park, J.H., Cording, S., et al. Mucosal immunology. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 349 (2015), 989–993.
34. 34 Williams, B.L., Hornig, M., Parekh, T., et al. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio, 3, 2012 e00261–11.
35. 35 Choi, G.B., Yim, Y.S., Wong, H., et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351 (2016), 933–939.
36. 36 Barbara, G., Stanghellini, V., De Giorgio, R., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004), 693–702.
37. 37 Barbara, G., Wang, B., Stanghellini, V., et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132 (2007), 26–37.
38. 38 Hildebrand, F., Tadeo, R., Voigt, A.Y., et al. LotuS: an efficient and user-friendly OTU processing pipeline. Microbiome, 2, 2014, 30.
39. 39 Edgar, R.C., UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10 (2013), 996–998.
40. 40 Ritari, J., Salojarvi, J., Lahti, L., et al. Improved taxonomic assignment of human intestinal 16S rRNA sequences by a dedicated reference database. BMC Genomics, 16, 2015, 1056.
41. 41 Quast, C., Pruesse, E., Yilmaz, P., et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41 (2013), D590–D596.
42. 42 Anderson, G.M., Feibel, F.C., Cohen, D.J., Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci 40 (1987), 1063–1070.
43. 43 Parks, D.H., Tyson, G.W., Hugenholtz, P., et al. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30 (2014), 3123–3124.
44. 44 Boccuto, L., Chen, C.F., Pittman, A.R., et al. Decreased tryptophan metabolism in patients with autism spectrum disorders. Mol Autism, 4, 2013, 16.
45. 45 Muller, C.L., Anacker, A.M., Veenstra-VanderWeele, J., The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 321 (2016), 24–41.
46. 46 Masi, A., Quintana, D.S., Glozier, N., et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20 (2015), 440–446.
47. 47 Gabriele, S., Sacco, R., Persico, A.M., Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol 24 (2014), 919–929.
48. 48 Finegold, S.M., Molitoris, D., Song, Y., et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35 (2002), S6–S16.
49. 49 Song, Y., Liu, C., Finegold, S.M., Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70 (2004), 6459–6465.
50. 50 Parracho, H.M., Bingham, M.O., Gibson, G.R., et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54 (2005), 987–991.
51. 51 Son, J.S., Zheng, L.J., Rowehl, L.M., et al. Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons simplex collection. PLoS One, 10, 2015, e0137725.
52. 52 Raymond, F., Ouameur, A.A., Deraspe, M., et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J 10 (2016), 707–720.
53. 53 Cook, E.H., Leventhal, B.L., The serotonin system in autism. Curr Opin Pediatr 8 (1996), 348–354.
54. 54 Saulnier, D.M., Riehle, K., Mistretta, T.A., et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141 (2011), 1782–1791.
55. 55 Chumpitazi, B.P., Cope, J.L., Hollister, E.B., et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 42 (2015), 418–427.
56. 56 Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., et al. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232 (2011), 196–199.
57. 57 Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25 (2011), 40–45.
58. 58 Hsiao, E.Y., McBride, S.W., Chow, J., et al. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci U S A 109 (2012), 12776–12781.
59. 59 Wu, W.L., Adams, C.E., Stevens, K.E., et al. The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring. Brain Behav Immun 46 (2015), 192–202.
60. 60 Hsiao, E.Y., Patterson, P.H., Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 25 (2011), 604–615.
61. 61 Singh, V.K., Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 66 (1996), 143–145.
62. 62 Pagan, C., Delorme, R., Callebert, J., et al. The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl Psychiatry, 4, 2014, e479.
63. 63 Marler, S., Ferguson, B.J., Lee, E.B., et al. Brief report: whole blood serotonin levels and gastrointestinal symptoms in autism spectrum disorder. J Autism Dev Disord 46 (2016), 1124–1130.
64. 64 Margolis, K.G., Li, Z., Stevanovic, K., et al. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J Clin Invest 126 (2016), 2221–2235.